Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,319 Depression
clinical trials

Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Status: Enrolling, Phase III
Updated: 4/1/2015
mi
from
Birmingham, AL
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Status: Enrolling, Phase III
Updated: 4/1/2015
mi
from
Jacksonville Beach, FL
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Status: Enrolling, Phase III
Updated: 4/1/2015
mi
from
Miami, FL
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Status: Enrolling, Phase III
Updated: 4/1/2015
mi
from
Orange City, FL
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Status: Enrolling, Phase III
Updated: 4/1/2015
mi
from
Watertown, MA
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Arlington, TX
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Atlanta, GA
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Bradenton, FL
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Chicago, IL
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Lauderhill, FL
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Rockville, MD
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
San Diego, CA
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Hartford, CT
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 3/29/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 3/29/2016
mi
from
Charleston, SC
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 3/29/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 3/29/2016
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 3/29/2016
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 3/29/2016
mi
from
Oceanside, CA
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 3/29/2016
mi
from
Orange, CA
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 3/29/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Bothel, WA
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Brockton, MA
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Durham, NC
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Libertyville, IL
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Media, PA
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Memphis, TN
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Scranton, PA
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Birmingham, AL
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Maitland, FL
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Mt. Pleasant, SC
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Norristown, PA
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
Treatment-Resistant Depression Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
San Rafael, CA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
A Study of Ketamine in Patients With Treatment-resistant Depression
Status: Enrolling, Phase II
Updated: 1/25/2016
mi
from
Atlanta, GA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
A Study of Ketamine in Patients With Treatment-resistant Depression
Status: Enrolling, Phase II
Updated: 1/25/2016
mi
from
Charleston, SC
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Beachwood, OH
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Canton, OH
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Coral Springs, FL
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Durham, NC
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Gainsville, FL
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
New York, NY
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
North Miami, FL
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Ocala, FL
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Torrance, CA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Naperville, IL
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Orange, CA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Wildomar, CA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
A Study of Ketamine in Patients With Treatment-resistant Depression
Status: Enrolling, Phase II
Updated: 1/25/2016
mi
from
Allentown, PA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
A Study of Ketamine in Patients With Treatment-resistant Depression
Status: Enrolling, Phase II
Updated: 1/25/2016
mi
from
New York, NY
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
A Study of Ketamine in Patients With Treatment-resistant Depression
Status: Enrolling, Phase II
Updated: 1/25/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Kirkland, WA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Libertyville, IL
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Little Rock, AR
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Oceanside, CA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Riverside, CA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Boston, MA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Denver, CO
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Flowood, MS
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Jenkintown, PA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Media, PA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Rochester, NY
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
A Study of Ketamine in Patients With Treatment-resistant Depression
Status: Enrolling, Phase II
Updated: 1/25/2016
mi
from
Little Rock, AR
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Psychiatry / Psychology Clinical Trial
COPES Phase I Randomized Controlled Trial of Treatment For Distress in Heart Disease Patients
Status: Enrolling
Updated: 2/4/2016
mi
from
New York, NY
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Memphis, TN
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Norristown, PA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Oakland, CA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Prairie Village, KS
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Redlands, CA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Roswell, GA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
A Study of Ketamine in Patients With Treatment-resistant Depression
Status: Enrolling, Phase II
Updated: 1/25/2016
mi
from
Dallas, TX
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
A Study of Ketamine in Patients With Treatment-resistant Depression
Status: Enrolling, Phase II
Updated: 1/25/2016
mi
from
New Haven, CT
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Arlington, TX
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Lauderhill, FL
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Roanoke, VA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Victorville, CA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Watertown, MA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Atlanta, GA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Status: Enrolling, Phase II
Updated: 4/2/2016
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
1 5 6 7 8 9 10 11 12 13